Your browser is no longer supported. Please, upgrade your browser.
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSYS Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.56 Insider Own65.92% Shs Outstand75.17M Perf Week-13.90%
Market Cap484.09M Forward P/E- EPS next Y-0.03 Insider Trans0.00% Shs Float24.99M Perf Month-21.84%
Income-184.70M PEG- EPS next Q-0.15 Inst Own28.00% Short Float48.75% Perf Quarter2.55%
Sales164.10M P/S2.95 EPS this Y-86.60% Inst Trans-4.43% Short Ratio7.33 Perf Half Y-32.99%
Book/sh1.47 P/B4.38 EPS next Y-2.50% ROA-2.10% Target Price9.80 Perf Year-40.48%
Cash/sh1.62 P/C3.98 EPS next 5Y28.00% ROE-3.10% 52W Range4.10 - 15.02 Perf YTD-33.06%
Dividend- P/FCF59.04 EPS past 5Y16.50% ROI2.40% 52W High-57.12% Beta1.00
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin84.30% 52W Low57.07% ATR0.48
Employees423 Current Ratio0.90 Sales Q/Q-83.60% Oper. Margin-9.30% RSI (14)31.30 Volatility5.48% 6.21%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin-4.30% Rel Volume1.17 Prev Close6.93
ShortableYes LT Debt/Eq0.00 EarningsMar 08 AMC Payout- Avg Volume1.66M Price6.44
Recom2.00 SMA20-15.57% SMA50-25.24% SMA200-28.74% Volume1,937,730 Change-7.07%
Mar-09-18Downgrade Piper Jaffray Neutral → Underweight
Oct-11-17Reiterated RBC Capital Mkts Outperform $14
Aug-04-17Reiterated RBC Capital Mkts Outperform $16 → $14
May-10-17Downgrade Piper Jaffray Overweight → Neutral
Dec-21-16Reiterated RBC Capital Mkts Outperform $23 → $16
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Mar-16-18 06:32PM  5 doctors charged with taking kickbacks to tout painkiller Associated Press -7.07%
05:37PM  Five New York doctors charged with taking kickbacks from Insys Reuters
02:07PM  Five New York doctors charged with taking kickbacks from Insys Reuters
01:43PM  Five New York doctors charged with taking kickbacks from Insys Reuters
Mar-13-18 06:32AM  Is Beaten-Down Marijuana Stock Insys Therapeutics a Bad-News Buy? Motley Fool
Mar-12-18 04:16PM  Top 4 Marijuana Stocks to Watch Investopedia
Mar-10-18 12:51PM  Ivy League Doctor Gets 4 Years in Prison for Insys Opioid Kickbacks Fortune
Mar-09-18 03:47PM  Doctor in Insys opioid kickback scheme gets four years in prison Reuters
02:24PM  Ivy League Doctor Gets 4 Years in Prison for Insys Opioid Kickbacks Bloomberg
01:27PM  Piper Jaffray Loses Confidence In Insys Therapeutics, Downgrades Stock Benzinga
06:00AM  Rhode Island doctor in Insys opioid kickback probe faces sentencing Reuters
05:01AM  Insys Therapeutics reports 4Q loss Associated Press
Mar-08-18 07:09PM  Drugmaker Insys loss widens on lower Subsys sales Reuters
05:56PM  After-hours buzz: MAT, HAS, UNFI & more CNBC
04:31PM  Drugmaker Insys reports bigger loss on lower Subsys sales Reuters
04:15PM  INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
02:00PM  Insys Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
07:31AM  All You Need To Know About INSYS Therapeutics Incs (NASDAQ:INSY) Risks Simply Wall St.
Mar-06-18 04:35PM  Opioid Maker Insys Still Has Fans on Wall Street The Wall Street Journal
12:24AM  Opioid Maker Insys Still Has Fans on Wall Street The Wall Street Journal
Mar-02-18 10:00AM  The deadly trap of opioid painkiller addiction CNBC +6.29%
08:30AM  INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms GlobeNewswire
08:00AM  New Research: Key Drivers of Growth for New Media Investment Group, Perficient, Strayer Education, Regulus Therapeutics, Kelly Services, and Insys Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-01-18 09:00AM  INSYS Therapeutics Confirms Completion of Founders Independent Trust GlobeNewswire
Feb-26-18 05:39PM  Doctor tied to Insys opioid kickback probe gets prison term Reuters
Feb-25-18 08:09PM  Four Marijuana Stocks to Buy Now Insider Monkey
Feb-23-18 09:00AM  INSYS Therapeutics to Report Fourth Quarter 2017 Results on March 8 GlobeNewswire
Feb-20-18 11:47AM  Wonder Women Of Weed: Jodie Emery, The Entrepreneurial Rebel With A Cause Benzinga
09:13AM  INSYS Therapeutics to Present at RBC Healthcare Conference GlobeNewswire
Feb-13-18 03:08PM  Opioid Litigants Get Boost From Senate Report
Feb-12-18 07:30PM  Opioid makers paid millions to advocacy groups -U.S. Senate report Reuters
Feb-09-18 11:38AM  Stocks give up early gains, Trump signs budget bill Yahoo Finance
11:22AM  INSYS Therapeutics Addresses Maryland Attorney Generals Motion GlobeNewswire
Feb-08-18 04:19PM  Maryland sues Insys to enforce subpoena in opioid probe Reuters -5.95%
03:44PM  Maryland sues Insys to enforce subpoena in opioid probe Reuters
Feb-05-18 03:30PM  See which Valley public companies were among U.S. stocks that suffered the most last week American City Business Journals
Feb-02-18 08:26AM  Look Beyond Pharma to Invest in Marijuana Industry Insider Monkey
Feb-01-18 11:23PM  New York accuses Insys of deceptively marketing opioid Reuters -6.66%
11:00PM  INSYS Therapeutics Addresses New York Attorney Generals Complaint GlobeNewswire
03:32PM  New York accuses Insys of deceptively marketing opioid Reuters
02:49PM  New York accuses Insys of deceptively marketing opioid Reuters
09:00AM  INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors GlobeNewswire
Jan-30-18 09:00AM  INSYS Therapeutics Adds Two New Executives to Senior Management Team GlobeNewswire
Jan-24-18 03:30PM  Cannabis Industry Group Announces National Standards, Starts With Marijuana Product Packaging And Labeling Benzinga
Jan-23-18 02:45PM  What Vermont Can Learn from Washingtons Marijuana Tax Market Realist +7.82%
01:12PM  Vermont Legalizes Recreational Marijuana on January 22, 2018 Market Realist
10:32AM  The Other Side of Legalizing Recreational Marijuana Market Realist
09:02AM  What a Country Could Gain from Legalizing Recreational Marijuana Market Realist
07:33AM  The Marijuana Ecosystems Potential Business Opportunities Market Realist
Jan-22-18 10:33AM  Is Investment in the Marijuana Space Picking Up? Market Realist +10.36%
09:04AM  The Motivation for Recreational Marijuana Consumption Market Realist
07:37AM  Why the Medical Marijuana Industry Is Growing Market Realist
Jan-19-18 05:20PM  How Marijuana Acceptance Is Evolving Globally Market Realist
03:45PM  Must-Knows before Investing in the Marijuana Industry Market Realist
Jan-18-18 01:16PM  Colorado Cannabis Sales Hit $1.49 Billion In 2017: Taxes Up To $247 Million, Medical Sales Down To $420 Million Benzinga -5.12%
Jan-15-18 09:05AM  What Are Insys Therapeutics Top Priorities? Market Realist
09:04AM  How Investors Can Access the Marijuana Industry Market Realist
07:37AM  Insys Has Legal Issues Galore Market Realist
07:36AM  Why Canada May Be Legalizing Cannabis for Recreational Use This Year Market Realist
Jan-12-18 05:20PM  Whats behind Insys Therapeutics Legal Tangles? Market Realist
03:50PM  A Look at Insys Therapeutics Financial Performance Market Realist
02:55PM  Gauging Marijuana Risk: The Potential Investment Blowback Market Realist
02:17PM  What Analysts Recommend for Insys Therapeutics and Peers Market Realist
01:25PM  The Arrival of Marijuana Market Realist
11:54AM  Should You Jump on the Marijuana Bandwagon? Market Realist
Jan-11-18 04:14PM  Ex-Insys employee seeks ban on mentioning 'opioid crisis' at trial Reuters
12:17PM  How to Make Some Green From Marijuana Stocks InvestorPlace
Jan-10-18 09:52AM  'New' Fund Soars To Record High: Is Cannabis The New Bitcoin? Investor's Business Daily
Jan-08-18 07:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insys Therapeutics, LGI Homes, Steelcase, AtriCure, Alliance Holdings GP, and Digital Turbine New Research Emphasizes Economic Growth GlobeNewswire
Jan-07-18 09:08AM  Your 2018 Guide to Investing in Marijuana Stocks Motley Fool
Jan-06-18 10:34AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jan-05-18 07:00PM  What's Behind This Marijuana Stock Soaring 81.5% in December? Motley Fool +8.52%
08:10AM  Todays Research Reports on Trending Tickers: Aurinia Pharmaceuticals Inc. and INSYS Therapeutics, Inc. ACCESSWIRE
Jan-04-18 09:00PM  Here's Why Marijuana Stocks Got Crushed Today Motley Fool -26.31%
04:30PM  Why Buckle, Insys Therapeutics, and United Natural Foods Slumped Today Motley Fool
01:11PM  Why Insys Therapeutics Inc. Crashed Today Motley Fool
03:00AM  Stocks Showing Rising Market Leadership: Insys Therapeutics Earns 89 RS Rating Investor's Business Daily
Jan-03-18 02:34PM  Why Insys Therapeutics Inc Is Up Double Digits for the Second Straight Day Motley Fool +16.05%
09:00AM  INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference GlobeNewswire
08:55AM  Insys Stock Breaks Out, but How Long Will Rally Last? Investopedia
08:21AM  This High-Risk, High-Reward Marijuana Stock Almost Doubled in December Motley Fool
Jan-02-18 09:01PM  Why This Tiny Marijuana Stock Just Doubled Motley Fool +19.85%
05:16PM  The 2 Simple Reasons Behind This Marijuana Stock's 19% Jump Higher Motley Fool
03:17PM  Best Biotech Stock Trades and Mergers to Watch in 2018
Jan-01-18 11:41AM  ETFs with exposure to INSYS Therapeutics, Inc. : January 1, 2018 Capital Cube
Dec-30-17 03:58PM  Pot Stock Winners of the Week Investopedia
10:37AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Dec-29-17 06:45AM  What Does INSYS Therapeutics Incs (NASDAQ:INSY) Ownership Structure Look Like? Simply Wall St. +11.60%
Dec-28-17 04:30PM  Why Insys Therapeutics, Energous, and Southwestern Energy Jumped Today Motley Fool +10.94%
Dec-27-17 11:29AM  Insys' Cannabidiol Gets Fast Track Designation in the U.S. Zacks -5.24%
08:40AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
08:31AM  INSYS Therapeutics (INSY) Soars: Stock Adds 15.2% in Session Zacks
Dec-26-17 08:30AM  FDA Grants INSYS Therapeutics Fast Track Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome GlobeNewswire +15.17%
Dec-25-17 08:21AM  The All-or-Nothing Marijuana Stock for 2018 Motley Fool
Dec-22-17 06:02AM  3 Best Marijuana Biotech Stocks for 2018 Motley Fool
Dec-21-17 01:07PM  North Carolina accuses drugmaker Insys of scheme to push opioid Reuters
11:30AM  North Carolina sues drugmaker Insys over role in opioid epidemic Reuters
06:35AM  Why INSYS Therapeutics Inc (NASDAQ:INSY) Is A Financially Healthy Company Simply Wall St.
Dec-20-17 03:49PM  New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit Reuters
03:20PM  New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit Reuters
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is SYNDROS, an orally administered liquid formulation of dronabinol for treating CINV and anorexia associated with weight loss in patients with AIDS. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 11Buy8.9317,500156,33842,447,810Aug 14 12:38 PM
Motahari SaeedPresident & CEOAug 10Buy8.925,50049,05615,400Aug 10 02:42 PM
FOURTEAU PATRICKDirectorAug 04Option Exercise1.6210,00016,20069,682Aug 04 05:33 PM
Motahari SaeedPresident & CEOJun 14Buy11.105,40059,9559,900Jun 14 03:19 PM
Vishnoi RohitDirectorJun 01Buy14.144,00056,5754,000Jun 02 03:14 PM
FOURTEAU PATRICKDirectorMay 26Option Exercise3.6310,00036,30059,682May 26 04:26 PM
MEYER STEVEN JDirectorMay 18Buy12.218,00097,68052,083May 18 04:48 PM
Motahari SaeedPresident & CEOMay 16Buy11.984,50053,9324,500May 16 08:53 PM